دورية أكاديمية

Pros and Cons of Nebulizer Treatment in Asthma Exacerbation During the COVID-19 Pandemic.

التفاصيل البيبلوغرافية
العنوان: Pros and Cons of Nebulizer Treatment in Asthma Exacerbation During the COVID-19 Pandemic.
المؤلفون: ÖZTÜRK, Ayşe Bilge, BACCIOĞLU, Ayşe, UYSAL SOYER, Özge, CIVELEK, Ersoy, ŞEKEREL, Bülent Enis, BAVBEK, Sevim
المصدر: Asthma Allergy Immunology / Astim Allerji Immunoloji; Apr2021, Vol. 19 Issue 1, p1-5, 5p
مصطلحات موضوعية: ASTHMA treatment, RESPIRATORY therapy equipment, AEROSOLS, PREVENTION of communicable diseases, PREVENTIVE health services, COVID-19 pandemic, DISEASE exacerbation, PATIENT safety
مستخلص: Nebulizers generate aerosols and may potentially transmit respiratory viral particles including SARS-CoV-2. There is a great concern about the use of a nebulizer in the treatment of asthma exacerbations in the hospital or home setting during the COVID-19 pandemic and its use is not recommended unless essential. However, aerosol therapy should not be avoided in obligatory indications. Therefore, indications of nebulizer use during the pandemic should be evaluated on an individual basis in case of a severe asthma attack, and infection control recommendations should be followed by clinicians while using nebulizers. In this article, we aimed to assess the safety in addition to the "pro" and "con" sides of nebulizer treatment in asthma exacerbation during the COVID-19 pandemic. [ABSTRACT FROM AUTHOR]
Copyright of Asthma Allergy Immunology / Astim Allerji Immunoloji is the property of Turkish National Society of Allergy & Clinical Immunology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index